LOBEF (Lobe Sciences) 3-Month Share Buyback Ratio: -14.36% (As of May. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lobe Sciences 3-Month Share Buyback Ratio?

Lobe Sciences LOBEF 3-Month Share Buyback Ratio is -14.36 as of May. 2026. The stock has 2 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Lobe Sciences's current 3-Month Share Buyback Ratio was -14.36%.

Lobe Sciences  (OTCPK:LOBEF) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Lobe Sciences 3-Month Share Buyback Ratio Related Terms

LOBEF vs VRTX, REGN, RVMD: 3-Month Share Buyback Ratio Comparison

For the Biotechnology subindustry, Lobe Sciences's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lobe Sciences 3-Month Share Buyback Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's 3-Month Share Buyback Ratio falls into.


Lobe Sciences 3-Month Share Buyback Ratio Calculation

Lobe Sciences's 3-Month Share Buyback Ratio for the quarter that ended in May. 2026 is calculated as

3-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Feb. 2026 ) - Shares Outstanding (EOP) (May. 2026 )) / Shares Outstanding (EOP) (Feb. 2026 )
=(269.487 - 308.182) / 269.487
=-14.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 3-Month Share Buyback Ratio of -14.36 mean?
Lobe Sciences (LOBEF) has a 3-Month Share Buyback Ratio of -14.36 as of May. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Lobe Sciences and its competitors.
Is Lobe Sciences' 3-Month Share Buyback Ratio too high?
Lobe Sciences' current 3-Month Share Buyback Ratio is -14.36.
How does Lobe Sciences' 3-Month Share Buyback Ratio compare to VRTX and REGN?
Lobe Sciences' 3-Month Share Buyback Ratio of -14.36 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Biotechnology company?
A good 3-Month Share Buyback Ratio depends on the Biotechnology industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Lobe Sciences and its competitors. Lobe Sciences's current 3-Month Share Buyback Ratio is -14.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current 3-Month Share Buyback Ratio of -14.36. The current 3-Month Share Buyback Ratio is -14.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current 3-Month Share Buyback Ratio is -14.36 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lobe Sciences Business Description

Other Exchanges LOBE:GermanyLOBE:Canada
Address 1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.